Skip to content

Therapeutic Effects of Kinesiotape in the Management of Gonarthrosis

Therapeutic Effects of Kinesiotape in the Management of Gonarthrosis: A Randomized Controlled Approach

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07124169
Enrollment
38
Registered
2025-08-15
Start date
2015-11-30
Completion date
2016-06-30
Last updated
2025-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gonarthrosis

Keywords

gonarthrosis, kinesiotape, home exercises

Brief summary

This randomized controlled trial evaluated the effectiveness of kinesiotaping in addition to exercise for patients with knee osteoarthritis (gonarthrosis). Thirty-eight participants aged 45 to 65 were randomly assigned to two groups: one group performed a structured home exercise program three times weekly for 6 weeks, while the other group performed the same program and also received kinesiotaping once weekly. Outcomes included pain, stiffness, balance, and quality of life. Both groups demonstrated significant improvement; however, the kinesiotaping plus exercise group showed greater gains in pain reduction, mobility, and daily activities. These findings suggest that kinesiotaping combined with exercise may provide superior benefits compared with exercise alone in individuals with knee osteoarthritis.

Interventions

OTHERKinesiotape + home exercise

Kinesiotaping will be applied to the knee once weekly for 6 weeks. In addition, participants will perform a structured home exercise program three times per week, including strengthening, stretching, and balance exercises.

OTHERHome exercise

In addition, participants will perform a structured home exercise program three times per week, including strengthening, stretching, and balance exercises.

Sponsors

Fenerbahce University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* having a diagnosis of primary gonarthrosis according to ACR classification criteria, * being between 45 and 65 years of age, * having a radiological diagnosis of gonarthrosis between Kellgren-Lawrence stage 1-3 , * signing the informed consent

Exclusion criteria

* presence of a neurological disorder affecting muscle strength or balance, * history of any surgical operation on the knee, hip or spine, * physiotherapy or injections for the knee within the previous year, * presence of systemic conditions such as diabetes mellitus, vertigo, visual problems, * history of severe trauma within the previous year

Design outcomes

Primary

MeasureTime frameDescription
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)From enrollment to the end of treatment at 6 weeksWOMAC consists of 24 questions in total (pain 5, joint stiffness 2, functional status 17). Each question was scored on a scale of 1-5. A high score indicates poor health, while a low score indicates good health.

Secondary

MeasureTime frameDescription
Visual Analogue Scale (VAS)From enrollment to the end of treatment at 6 weeksVAS, which ranges from 0 to 10, is used to assess pain levels. A score of 0 represents no pain, while 10 indicates the most severe, unbearable pain. Participants were instructed to indicate their perceived pain level by marking a 10 cm straight line, and the corresponding value was recorded in centimeters.
Berg Balance Scale (BBS)From enrollment to he end of treatment at 6 weeks.BBS is a test consisting of 14 items used to evaluate the functional balance of individuals. The application time is approximately 15-20 minutes, and the following materials are needed: a ruler, a stopwatch, a chair, a step, and an area suitable for 360-degree rotation. Each item is evaluated on a scale of 0-4 points based on the individual's ability to perform the given task independently and correctly. The total score is 56. A score between 0-20 indicates severe balance impairment, between 21-40 indicates acceptable balance, and between 41-56 indicates good balance.
Short Form (SF-36)From enrollment to the end of treatment at 6 weeksThe SF-36 questionnaire was developed to assess quality of life. A total of 8 sub-parameters, including pain, social functioning, energy/vitality, emotional role difficulties, physical role difficulties, physical functioning, general health perception, and mental health, are examined

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026